Company Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Equities
US68403P1049
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -50.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 11/04/02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 11/04/02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13/04/13 |
Leonard Sank
BRD | Director/Board Member | 59 | 22/10/07 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 08/01/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 11/04/02 |
Miriam Kidron
FOU | Founder | 83 | 11/04/02 |
Leonard Sank
BRD | Director/Board Member | 59 | 22/10/07 |
Arie Mayer
BRD | Director/Board Member | 67 | 04/12/19 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 30/04/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,628,924 | 36,048,040 ( 88.73 %) | 0 | 88.73 % |
Company contact information
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.comSector
1st Jan change | Capi. | |
---|---|---|
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- ORMP Stock
- Stock
- Company Oramed Pharmaceuticals, Inc.